Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	Your Love Life on Ozempic - 20 days ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - 22 days ago GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration? - 3 months ago Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 4 months ago FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 4 months ago
3	Will Norman PV Tech Senior reporter. London clean energysupply chainsmanufacturingtrade policyhuman rights	X-Elio signs 245GWh virtual PPA with pharmaceutical decarbonisation group - 26 days ago Encavis, LyondellBasell ink PPA for 260MW German PV project - 11 months ago Lightsource bp signs corporate PPA with Microsoft for Polish PV - over 1 year ago
4	Emily Cooke Live Science Health reporter. London, United Kingdom healthscience	People with this rare genetic condition can't repair damage to their DNA - 26 days ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender - 2 months ago Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings - 4 months ago Roche Weighs In With Encouraging Early Clinical Data for Oral GLP-1 Drug - 8 months ago Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think - 8 months ago Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush - 9 months ago
6	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	GLP-1 drugs spark disagreements in Trump’s circle - 3 months ago Versant enters obesity with new startup - 3 months ago
7	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - 3 months ago
8	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - 3 months ago Data Show Lepodisiran Was Well Tolerated, Substantially Lowered Lipoprotein (a) - over 1 year ago
9	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Pharma giants vie for oral GLP-1R approval - 3 months ago
10	The Conversation Science Alert Science news. Official account. Australia science news	Ozempic vs Supplements: Dietitian Reveals Truth About GLP-1 Imitations - 3 months ago

Journalists covering lgp4